DHE also has poor oral bioavailability, but its cardiovascular risks were considered somewhat less severe than ergotamine’s. It was available in the United States only for subcutaneous (SC), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback